Table of contents

• Stem Cell Injection at a Glance
• What Is Stem Cell Injection?
• Who Is a Good Candidate for Stem Cell Injection?
• How Is Stem Cell Injection Performed?
• Why Visit Korea for Stem Cell Injection?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Stem Cell Injection?
• Stem Cell Injection From Start to Finish
• Alternatives to Stem Cell Injection
• How Can I Prepare for Stem Cell Injection?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

Stem Cell Injection at a Glance

• Not one standard procedure — Stem cell injection can mean a local joint or tendon injection, IV infusion, intrathecal treatment, tissue harvest, or surgical implantation; the cell source, processing, dose, route, and diagnosis determine the risks, evidence, recovery, and itinerary.
• Costs require a written quote — No reliable standard price applies because there is no single stem cell injection procedure; obtain an itemized proposal identifying the exact product or trial, harvesting or manufacturing fees, administration route, monitoring, follow-up, and any surgery or rehabilitation costs before paying.
• Recovery ranges from days to months — A simple non-sedated local injection may allow same-day discharge with 24–72 hours of relative rest, while fat or bone-marrow harvesting adds donor-site recovery and arthroscopic or open implantation requires rehabilitation over weeks to months.
• Results and repeat sessions are uncertain — There is no evidence-based universal timeline for results or maintenance injections; for knee osteoarthritis, low-certainty evidence suggests modest pain and function improvement for up to six months, not proven cartilage regrowth or prevention of joint replacement.
• Best for a defined diagnosis — Appropriate candidates have a confirmed condition and tissue target, specialist assessment, a condition-specific lawful treatment or research pathway, realistic expectations, and the ability to complete monitoring and follow-up.
• Korea requires pathway verification — Korea’s advanced-regenerative-medicine framework provides oversight and traceability, but it is not blanket approval for advertised injections; confirm in writing whether the proposal uses an MFDS-authorized product within its indication, a formal clinical study, or a reviewed treatment pathway.
• Plan travel around the exact method — For an outpatient, ready-to-administer, non-sedated local injection, plan at least 3–5 days in Korea; culture-expanded autologous cells may require a later administration date or second trip, while arthroscopic or open procedures commonly require at least 7–14 days locally before international travel.

What Is Stem Cell Injection?

Stem cell injection is an umbrella term for administering a patient’s own or donor-derived cell product locally, into the bloodstream, or alongside another procedure. It aims to address a defined disease or tissue problem, though symptom relief, tissue repair, and lasting benefit are different outcomes. It can be minimally invasive or surgical, depending on the cell product, delivery route, and whether tissue harvesting or implantation is required.

Who Is a Good Candidate for Stem Cell Injection?

• Defined medical target — Suitable evaluation starts with a confirmed diagnosis, a specific tissue or disease target, and a realistic clinical goal rather than a general request for “rejuvenation.”
• Condition-specific pathway — Candidates need a proposal identifying an MFDS-authorized product used within its indication, a formal clinical study, or an appropriately reviewed advanced-regenerative-medicine treatment pathway.
• Specialist assessment — The relevant specialist, such as an orthopedic surgeon for a joint condition or a gastroenterologist and colorectal surgeon for inflammatory bowel disease, must assess whether established care is more appropriate.
• Capacity for monitoring — International patients need enough time for pre-treatment assessment, post-procedure observation, flight clearance, and coordinated follow-up at home.
• Informed expectations — Good candidates understand that pain relief, tissue repair, disease modification, and long-term durability are separate outcomes. For knee osteoarthritis, a Cochrane review found only low-certainty evidence of modest pain and function improvement up to six months, not proof of cartilage regrowth or avoidance of joint replacement.

Do not proceed with a proposal that lacks a condition-specific regulatory route, clinical-research protocol, or reviewed treatment plan. Active infection, fever, untreated dental or skin infection, pregnancy or breastfeeding, and inability to complete monitoring generally require deferral. Bleeding disorders, severe thrombocytopenia, anticoagulant or antiplatelet use, uncontrolled diabetes, unstable heart or lung disease, kidney or liver dysfunction, cancer history, immunosuppression, and prior thrombosis require route- and product-specific specialist review. There is no universal age threshold: eligibility depends on the diagnosis, the product pathway, skeletal maturity where orthopedic treatment is considered, and the ability to provide informed consent.

How Is Stem Cell Injection Performed?

“Stem cell injection” describes the route of administration, not one uniform product or procedure. Cell source, processing, dose, and treatment target determine whether it is a short outpatient intervention, a staged treatment, or surgery with rehabilitation.

• Autologous, minimally manipulated cells — Fat or bone marrow is collected from the patient, processed, and returned during the same treatment episode. This avoids donor-cell exposure but adds harvest-site pain, bruising, bleeding, infection, and anesthesia risks.
• Autologous culture-expanded cells — Cells are collected and then expanded before later release and administration. Manufacturing and release testing usually mean treatment cannot be completed in one visit.
• Allogeneic donor-derived cells — Donor-cell products avoid harvesting from the recipient, but require clear documentation of donor screening, traceability, product characterization, storage, dose, and the applicable authorization or research pathway.
• Local or image-guided injection — Cells are delivered into or around a defined target, such as a joint or tendon, often using ultrasound or fluoroscopic guidance. Local placement is not equivalent to systemic therapy.
• Intravenous infusion — Cells are infused into the bloodstream under a diagnosis-specific protocol. An IV route does not establish benefit for unrelated conditions and requires an observation and adverse-event plan.
• Arthroscopic or open implantation — Cells can be combined with a scaffold or implanted during cartilage surgery. Recovery then follows the orthopedic operation, with rehabilitation lasting weeks to months.
• Not exosomes or SVF by default — Exosomes, stromal vascular fraction (SVF), and cell-containing preparations are not interchangeable with defined stem-cell products. Request the exact composition and processing method; regulators warn that unapproved stem-cell and exosome products can cause serious harm.

Why Visit Korea for Stem Cell Injection?

Korea has a specific legal framework for advanced regenerative medicine and advanced biopharmaceuticals. That framework supports oversight and traceability, but it does not prove that a particular advertised injection is authorized, appropriate, or effective for an overseas visitor. Verify the exact product and pathway before booking.

• Defined regulatory roles — Korea’s MFDS includes a Cell and Gene Therapy Products Division responsible for evaluating the quality, safety, and efficacy of cell therapies, gene therapies, and tissue-engineered products.
• Risk-based legal framework — The Advanced Regenerative Medicine and Advanced Biopharmaceuticals Act framework distinguishes treatment risk partly by cell source and degree of manipulation. Higher-risk categories include embryo/iPS-cell therapies, animal-derived cells, and more-than-minimally manipulated donor cells; this classification is not a guarantee of efficacy.
• Serious-disease focus — As of September 7, 2026, the advanced-regenerative-medicine treatment pathway is directed to people with no alternative treatment, life-threatening serious disease, rare disease, or other intractable disease. The law also excludes non-covered cosmetic and plastic procedures from this framework.
• Foreign-patient registration requirement — Institutions attracting foreign patients must meet separate registration requirements under Korean law. Registration does not confirm eligibility for a particular cell-therapy pathway, product availability, English consent support, or overseas follow-up.
• Documentation standard to demand — Ask for the diagnosis, product or trial identifier, cell source, autologous or allogeneic status, dose, processing, route, regulatory pathway, named physician, adverse-event plan, and follow-up plan in writing.

Key Information for International Patients

• Minimum stay — For a genuinely outpatient, non-sedated local injection using a ready-to-administer product, plan at least 3–5 days for in-person assessment, treatment, observation, and pre-flight review. Do not treat this as a universal itinerary.
• Staged care — Harvested and culture-expanded autologous cells can require a later administration date or a second trip. Arthroscopic or open implantation commonly requires at least 7–14 days locally before international travel, and sometimes longer.
• Flights — Obtain written fitness-to-fly clearance from the treating institution. Harvesting, surgery, reduced mobility, lower-limb treatment, obesity, estrogen exposure, cancer, pregnancy or postpartum status, and previous venous thromboembolism increase clot-risk considerations during long-haul travel; CDC guidance identifies prolonged travel as a blood-clot risk factor.
• Activity and itinerary — A simple local injection can involve 24–72 hours of relative rest, but donor-site harvesting, neuraxial treatment, lower-limb procedures, and surgery impose more restrictive recovery plans. Keep sightseeing, hiking, spa visits, and long intercity transfers off the early itinerary until cleared.
• Companion and transport — Arrange a companion and private transport after sedation, general anesthesia, invasive harvesting, intrathecal administration, impaired mobility, or surgery. A companion is not inherently necessary after every non-sedated injection.
• Records and remote follow-up — Leave Korea with an English discharge summary documenting product source, lot or batch where applicable, route, dose, medicines given, restrictions, emergency contacts, and records for the home clinician. Confirm who will answer urgent questions after return and how adverse events will be reported.

Travel note: The treating institution—not a broker—must provide the treatment itinerary, observation plan, and flight-clearance plan after confirming the exact intervention.

Which Are the Best Clinics in Korea for Stem Cell Injection?

Listed below are some of the best clinics in Korea for stem cell injection.

1. Cellinique Clinic

For stem cell injection, you can expect a personalized program at Cellinique built around its NovaStem approach, which uses concentrated autologous blood in regenerative and aesthetic care. Your consultation can also consider whether the clinic’s complementary options are relevant to your skin, hair, or broader wellness goals.

• URL: Cellinique Clinic Website
• Location: Gangnam-gu, Seoul
• Procedure approach:
  • NovaStem is described as using concentrated autologous blood to support tissue regeneration, skin elasticity, and skin health.
  • The clinic also offers stem cell therapy as part of treatments focused on damaged tissue repair, metabolic function, and overall health.
• Medical focus:
  • Dr. Chris Gunwoo Kim leads a one-doctor clinic dedicated to stem cell research and personalized care.
  • Dr. Kim has presented on blood stem cells, tissue regeneration, SDF-1alpha injection, and Cellinique’s NovaStem Kit at aesthetic-medicine and professional society meetings.
• Related options:
  • Available complementary treatments include PRP, exosomes, NK cell therapy, blood purification, Radiesse, and stem cell fat grafting.
  • For hair concerns, the clinic lists stem cell hair loss injections and non-incision hair transplantation.

2. SH Clinic

At SH Clinic, your stem cell injection plan is determined after an in-person consultation and examination, with programs that span regenerative, anti-aging, hair-loss, musculoskeletal, and sexual-health concerns. The clinic’s Wellness & Anti-aging program is based on personalized stem cell treatment planning.

• URL: SH Clinic Website
• Location: Seocho-gu, Seoul
• Stem cell treatment areas:
  • The clinic lists programs for female and male sexual function, hair loss, skin and cosmetic rejuvenation, arthritis and disc disease, autoimmune disease, cerebral infarction, and dementia.
  • Its BMAC knee injection uses concentrated bone-marrow cells for arthritic knees.
• Personalized assessment:
  • Experienced medical staff provide treatment planning after an in-person consultation and examination.
  • SH combines stem cell therapy with gynecology services, including vaginal rejuvenation options such as stem cell injections and vaginal HIFU.

3. THEPLUS Plastic Surgery

For stem cell injection at THEPLUS Plastic Surgery, you can ask about its blood-based Buffy Coat extraction system, which the clinic says is designed to obtain a concentrated cell layer from a 60 cc blood sample for a single treatment. Stem cell treatment is offered within the clinic’s broader aesthetic and post-procedure care approach.

• URL: THEPLUS Plastic Surgery Website
• Location: Gangnam-gu, Seoul
• Treatment system:
  • THE PLUS describes a specialized system that extracts the Buffy Coat layer from sampled blood, with the clinic reporting recovery of more than 10% of the sample.
  • The clinic states that its kit includes a 30 ml FDA-approved anticoagulant and individually sterilized, packaged components.
  • THE PLUS states that the system is manufactured in the U.S. and FDA-approved.
• Surgical expertise:
  • The clinic’s surgeons include board-certified plastic surgeons with experience in rhinoplasty, facial contouring, breast surgery, and research or professional education roles.
  • Stem cell treatment is available alongside aesthetic procedures including facial fat grafting, thread lifting, facelift surgery, rhinoplasty, facial contouring, breast surgery, and liposuction.

Stem Cell Injection From Start to Finish

1. Send records before travel — Provide diagnostic reports, imaging, pathology when relevant, prior procedures, medication and allergy lists, infection history, and recent laboratory results. Use a virtual or English-language consultation to establish whether a condition-specific pathway is even available.
2. Receive a written proposal — Require the exact product or trial identifier, source, autologous or allogeneic status, cell count or dose, processing method, route, intended indication, realistic benefit, major risks, regulatory status, treating specialist, and follow-up plan.
3. Coordinate travel only after eligibility review — Confirm the number of local visits, whether harvesting or surgery is involved, required observation, companion needs, accommodation accessibility, and a flexible return flight. Culture-expanded products can require a later treatment date.
4. Complete in-person evaluation — The team reconfirms diagnosis, target anatomy, consent capacity, current health, and travel safety. Testing can include examination, CBC, kidney and liver function, glucose or HbA1c, coagulation tests for invasive procedures, infection screening, pregnancy testing, ECG or anesthesia review, and updated imaging when clinically relevant.
5. Review consent and product records — Consent should explain the purpose, expected outcome, alternatives, known and unknown risks, privacy and data sharing, withdrawal rights in research, and adverse-event reporting. For donor products, request identity, sterility, viability, and release records; for autologous products, request chain-of-identity and processing records.
6. Undergo harvesting or administration — A local injection can use local anesthetic and image guidance. Fat harvest, bone-marrow aspiration, arthroscopy, open implantation, intrathecal administration, or IV infusion requires route-specific monitoring and may involve sedation or anesthesia.
7. Recover and receive discharge clearance — A non-sedated local procedure can allow same-day discharge, while invasive harvesting, infusion, and surgery require longer observation. Receive written instructions covering wound or injection-site care, permitted analgesics, activity limits, emergency symptoms, and fitness to fly.
8. Complete local review and overseas follow-up — Attend the scheduled early review before departure. Send symptom updates, photographs of wound sites when requested, and test results to the Korean team and home clinician; seek local urgent care rather than waiting for remote advice when serious symptoms develop.

Alternatives to Stem Cell Injection

Alternatives must match the confirmed diagnosis rather than the marketing label of a cell product. Non-surgical treatment can reduce symptoms or support function with less procedural risk, while surgery can address structural disease but requires longer recovery; neither category should be presented as a generic substitute for every stem-cell proposal.

Diagnosis-Directed Standard Care

• Best for — Patients without a clearly authorized or evidence-supported cell-therapy pathway, or those who have not completed first-line treatment for the diagnosed condition.
• Tradeoff — Orthopedic pain often requires rehabilitation, strengthening, load management, bracing, analgesics, or standard injections where indicated. Inflammatory bowel disease, neurologic disease, and systemic illness require specialist-led disease-specific care rather than a generic regenerative injection.

Platelet-Rich Plasma (PRP)

• What it is — PRP uses a concentrated component of the patient’s own blood, not stem cells. It is commonly considered for selected musculoskeletal indications depending on the diagnosis and local standards of care.
• Tradeoff — It avoids cell culture and donor-cell questions, but evidence and suitability remain condition-specific. Read about PRP injection.

Platelet-Rich Fibrin (PRF)

• What it is — PRF is an autologous blood-derived fibrin preparation used in selected regenerative and wound-healing contexts.
• Tradeoff — It is distinct from a cell therapy and does not provide proof of structural regeneration for a particular disease. See PRF injection.

Orthopedic Surgery or Cartilage Procedures

• What it is — Arthroscopy, repair, reconstruction, osteotomy, or joint replacement can be considered when imaging, symptoms, mechanical problems, and failed conservative treatment support surgery.
• Tradeoff — Surgery has clearer structural aims for selected patients but entails anesthesia, wound healing, thrombosis prevention, and rehabilitation. For knee-specific claims, avoid assuming that a generic cell injection will regrow cartilage; see stem cells for knee cartilage regeneration.

How Can I Prepare for Stem Cell Injection?

• Verify the treatment identity — Before paying deposits or booking flights, obtain the diagnosis, exact product or trial identifier, cell source, dose, processing, route, legal pathway, physician name, hospital name, adverse-event plan, and return-home follow-up plan in writing.
• Disclose all medicines — Send a complete list of anticoagulants, antiplatelets, corticosteroids, diabetes medicines, antihypertensives, immunosuppressants, hormone therapy, prescription drugs, over-the-counter medicines, and supplements. Do not independently stop aspirin, warfarin, apixaban, rivaroxaban, clopidogrel, insulin, or other prescribed medicine.
• Report risk factors — Disclose prior cancer treatment, immune suppression, thrombosis, bleeding disorders, allergy to anesthetics or antibiotics, kidney or liver disease, diabetes control, pregnancy or breastfeeding, infection symptoms, and recent dental or skin infection.
• Follow fasting instructions exactly — Fasting is usually required only for sedation, general anesthesia, or surgery. A local non-sedated injection generally has different requirements; follow the anesthetic team’s instructions rather than generic internet advice.
• Avoid nicotine and alcohol — Stop nicotine as directed, especially when harvesting or surgery is planned, because wound healing is relevant. Avoid alcohol and recreational drugs for the interval specified by the clinical team, particularly before sedation or anesthesia.
• Plan accessible recovery — Book accommodation with easy transport, minimal stairs, and room for mobility aids when a lower-limb procedure, harvesting, or surgery is planned. Arrange a companion after sedation, invasive treatment, or mobility-limiting care.
• Keep travel flexible — Do not schedule an early return flight, strenuous tourism, hot baths, saunas, or long ground transfers until the team confirms the route-specific recovery plan.

Travel note: Bring printed and digital copies of imaging, laboratory results, medication lists, and emergency contacts. Ask whether your home clinician has agreed to manage routine follow-up before leaving home.

Confirm all medication changes, fasting, infection screening, arrival timing, companion requirements, and travel restrictions with the treating doctor; individualized instructions take precedence over this general guidance.

Aftercare Advice

Protect the treated area, complete the observation plan, and treat new systemic symptoms as urgent—not as a normal part of “regeneration.”

• Rest and activity — After a simple local injection, maintain relative rest for the clinician-specified period, often 24–72 hours, and avoid strenuous exercise until cleared. Follow stricter mobility and rehabilitation restrictions after harvesting, lower-limb treatment, arthroscopy, or open surgery.
• Injection and wound care — Keep injection, aspiration, or incision sites clean and dry as instructed. Do not massage, soak, swim, use saunas, or apply unapproved topical products over a puncture or wound site until the team permits it.
• Use only approved medicines — Take prescribed analgesics, antibiotics, anticoagulation, or other medicines exactly as directed. Do not start anti-inflammatory medicines, supplements, or leftover antibiotics without asking the treating clinician, particularly after a harvest or surgery.
• Watch for urgent warning signs — Seek urgent local care for fever or chills; rapidly worsening pain, redness, warmth, swelling, or drainage; hives, wheeze, chest tightness, or fainting; new weakness, numbness, severe headache, or other neurologic change; one-sided leg swelling; chest pain; shortness of breath; or coughing blood. Fever has been reported more often in trials of intravascular mesenchymal stromal-cell administration, but available evidence does not establish long-term safety across products, doses, routes, or clinics.
• Attend review before flying — Do not fly until the treating team confirms that wounds, mobility, symptoms, and thrombosis risk permit travel. Follow instructions on walking, hydration, compression, or anticoagulation during travel when prescribed.
• Assess results by the agreed endpoint — There is no evidence-based universal result timeline or maintenance schedule for generic stem-cell injections. Review objective measures, adverse events, and standard-care alternatives before considering any repeat treatment.

Follow the treating doctor’s instructions over general advice, keep all scheduled follow-ups, and contact the clinic promptly when anything appears wrong.